About University of California at San Francisco (PARENT)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at University of California at San Francisco (PARENT)
During the past decade, University of California at San Francisco (PARENT) conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University of California at San Francisco (PARENT)"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "European Network of Individualized Treatment in Endometrial Cancer - ENITEC" with 1 trials as a collaborator and "European Network of Translational Research in Ovarian Cancer - EUTROC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at University of California at San Francisco (PARENT)
According to Clinical.Site data, the most researched conditions in "University of California at San Francisco (PARENT)" are
"Breast Cancer" (2 trials), "Ulcerative Colitis" (2 trials), "Crohn Disease" (1 trials) and "Endometrial Neoplasms" (1 trials). Many other conditions were trialed in "University of California at San Francisco (PARENT)" in a lesser frequency.
Clinical Trials Intervention Types at University of California at San Francisco (PARENT)
Most popular intervention types in "University of California at San Francisco (PARENT)" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (2 trials), "Placebo" (2 trials), "RPC1063" (2 trials), "Sapanisertib" (2 trials) and "Capecitabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of California at San Francisco (PARENT)
The vast majority of trials in "University of California at San Francisco (PARENT)" are
4 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at University of California at San Francisco (PARENT)
Currently, there are NaN active trials in "University of California at San Francisco (PARENT)".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in University of California at San Francisco (PARENT),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of California at San Francisco (PARENT), 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".